That's a well packed schedule of presentations. I would assume with all the R&D happening around immunotherapy there would be more papers submitted than speaking slots so the review process would screen these down to the truly noteworthy and interesting. Looking forward to news from here on in, should make for some good breakfast reading to accompany the weetbix!